SALBAIR I TRANSHALER is a combination of Ipratropium and Levosalbutamol which belongs to the group of medicines called Bronchodilator agents and Adrenergic beta-agonists, respectively. SALBAIR I TRANSHALER is used in adults, adolescents, and children (aged 4 years and above) to manage/prevent bronchospasm (tightening of airway muscles) with reversible obstructive airway diseases such as asthma, COPD (inflammatory lung disease), bronchitis (inflammation of airways), and/or emphysema (lung disease that cause shortness of breath).

SALBAIR I TRANSHALER is not recommended for use in patients allergic to ipratropium, levosalbutamol, and/or atropine.

Before using SALBAIR I TRANSHALER, inform your doctor if you have high blood pressure, seizures, diabetes, narrow angle glaucoma (increased eye pressure), lung problems (such as asthma), heart problems (such as coronary insufficiency, cardiac arrhythmias), kidney problems (such as renal impairment), and/or liver problems (such as hepatic impairment).

SALBAIR I TRANSHALER is generally not recommended for use in pregnant women unless it is clearly necessary. It is advised to be used with caution in breastfeeding women only if necessary since it is not known whether the medicine passes through breast milk.

SALBAIR I TRANSHALER should be used with caution in children and adolescents (aged 4 to 18 years) and is advised to be used with caution in elderly patients (aged above 65 years) after consulting the doctor.

The most common side effects using SALBAIR I TRANSHALER are dry mouth, sore throat, stuffy nose, throat irritation, dizziness, headache, nausea, and/or vomiting. Consult your doctor if any of these symptoms worsens.